Geneos Wealth Management’s Smith & Wesson SWBI Stock Holding History

Geneos Wealth Management’s Portfolio SWBI Stock Details SWBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-300	Closed	-$3.87K	–	2167
2023 Q3	$3.87K	Hold	300	–	–	﹤0.01%	1810
2023 Q2	$3.91K	Sell	300 -300	-50%	-$3.66K	﹤0.01%	1801
2023 Q1	$7.39K	Hold	600	–	–	﹤0.01%	1628
2022 Q4	$5.21K	Sell	600 -900	-60%	-$9.48K	﹤0.01%	1692
2022 Q3	$15K	Sell	1,500 -2,043	-58%	-$27K	﹤0.01%	1420
2022 Q2	$47K	Hold	3,543	–	–	﹤0.01%	1307
2022 Q1	$53K	Buy	3,543 +53	+2%	+$891	﹤0.01%	1363
2021 Q4	$62K	Sell	3,490 -3,130	-47%	-$64.6K	﹤0.01%	1382
2021 Q3	$138K	Buy	6,620 +1,050	+19%	+$25.2K	0.01%	1028
2021 Q2	$172K	Buy	5,570 +2,359	+73%	+$49.4K	0.01%	913
2021 Q1	$55K	Hold	3,211	–	–	﹤0.01%	1580
2020 Q4	$56K	Buy	3,211 +413	+15%	+$6.83K	﹤0.01%	1404
2020 Q3	$44K	Sell	2,798 -192	-6%	-$3.39K	﹤0.01%	1315
2020 Q2	$44K	Buy	+2,990	New	+$27.8K	﹤0.01%	1273

Other funds holding SWBI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PCM

Punch Card Management Winter Park, Florida $271M AUM 11.49% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Geneos Wealth Management's SWBI Position: Q4 2023 in Review

Geneos Wealth Management sold out of Smith & Wesson (SWBI) in Q4 2023, closing a stake of 300 shares — an estimated $3.87K sold.

Geneos Wealth Management first reported a position in SWBI in Q2 2020 and held it in 14 quarters. The position peaked at $172K in Q2 2021. 179 funds tracked by Wall St. Rank hold SWBI as of Q4 2023.

Geneos Wealth Management reported no remaining Smith & Wesson position as of Q4 2023 after selling out during the quarter.
Geneos Wealth Management sold 300 Smith & Wesson shares in Q4 2023, an estimated $3.87K.
Geneos Wealth Management first reported a position in Smith & Wesson in Q2 2020 and held it in 14 quarters.
Geneos Wealth Management's Smith & Wesson position peaked at $172K in Q2 2021.
179 funds tracked by Wall St. Rank held Smith & Wesson as of Q4 2023.

Based on Geneos Wealth Management's 13F filing for Q4 2023, filed 26 Jan 2024.